We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
151
SPDR Gold Trust
GLD
$141B
$124M 0.13%
802,280
-131,629
-14% -$21.2M
BLK icon
152
Blackrock
BLK
$175B
$122M 0.12%
222,178
+1,626
+0.7% +$1.06M
SCHW
153
Charles Schwab
SCHW
$189B
$122M 0.12%
1,692,633
+255,322
+18% +$17.7M
IVW icon
154
iShares S&P 500 Growth ETF
IVW
$77.8B
$120M 0.12%
2,081,480
+719
+0% +$46.7K
BSV icon
155
Vanguard Short-Term Bond ETF
BSV
$45.6B
$120M 0.12%
1,603,583
-201,668
-11% -$15.4M
BTI icon
156
British American Tobacco
BTI
$124B
$120M 0.12%
3,377,669
-87,963
-3% -$3.52M
TTE icon
157
TotalEnergies
TTE
$193B
$120M 0.12%
2,572,818
+69,801
+3% +$3.51M
GSLC icon
158
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$16B
$119M 0.12%
1,682,276
+175,566
+12% +$13.8M
VTI icon
159
Vanguard Morningstar Total Stock Market ETF
VTI
$692B
$119M 0.12%
663,344
+50,814
+8% +$10.1M
CHRW icon
160
C.H. Robinson
CHRW
$17.6B
$119M 0.12%
1,230,626
+507,506
+70% +$54.5M
CI icon
161
Cigna
CI
$74.9B
$117M 0.12%
420,273
-23,992
-5% -$6.75M
RDVY icon
162
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
$117M 0.12%
2,996,478
-586,858
-16% -$25.2M
NXPI icon
163
NXP Semiconductors
NXPI
$59.8B
$116M 0.12%
789,461
-29,215
-4% -$4.89M
PYPL icon
164
PayPal
PYPL
$50.2B
$116M 0.12%
1,344,890
-17,152
-1% -$1.52M
IAU icon
165
iShares Gold Trust
IAU
$64.1B
$116M 0.12%
3,666,752
-125,261
-3% -$4.11M
MOAT icon
166
VanEck Morningstar Wide Moat ETF
MOAT
$12.3B
$113M 0.11%
1,884,790
+70,083
+4% +$4.71M
WFC icon
167
Wells Fargo
WFC
$264B
$113M 0.11%
2,807,969
+252,151
+10% +$10.8M
VWO icon
168
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$111M 0.11%
3,046,663
-110,555
-4% -$4.49M
ADSK icon
169
Autodesk
ADSK
$53.3B
$111M 0.11%
593,588
+56
+0% +$11.3K
VEA icon
170
Vanguard FTSE Developed Markets ETF
VEA
$236B
$109M 0.11%
2,995,699
-332,205
-10% -$13.5M
MRSH
171
Marsh
MRSH
$90.9B
$109M 0.11%
727,906
+4,438
+0.6% +$712K
EOG icon
172
EOG Resources
EOG
$73.5B
$109M 0.11%
971,116
-14,620
-1% -$1.64M
SHW icon
173
Sherwin-Williams
SHW
$87.7B
$108M 0.11%
527,463
-17,042
-3% -$4.04M
CAT icon
174
Caterpillar
CAT
$387B
$108M 0.11%
655,575
-28,556
-4% -$5.22M
SYK icon
175
Stryker
SYK
$130B
$106M 0.11%
523,939
+68,452
+15% +$14.4M

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.